Literature DB >> 34951005

Targeting AURKA by microRNA-490-3p suppresses gastric cancer cell growth.

Rui Chen1, Shenkang Zhou1, Chengfeng Fang1, Feifei Ye1, Jianhui Chen1, Pinlu Jiang2.   

Abstract

OBJECTIVE: To illustrate the molecular mechanism of microRNA-490-3p regulating gastric cancer (GC) cells by targeting AURKA.
METHODS: Genes with significantly different expression in GC and normal tissue in TCGA-STAD dataset were analyzed by bioinformatics. Expression levels of genes and proteins in GC cells were measured by qRT-PCR and western blot. The interaction between microRNA-490-3p and AURKA was verified by dual luciferase assay. Proliferation, migration, invasion and apoptosis of GC cells were evaluated through a set of cell function assays.
RESULTS: MicroRNA-490-3p was significantly less expressed in GC, while AURKA was significantly highly expressed. Dual luciferase reporter gene assay proved that microRNA-490-3p targeted AURKA. Up-regulation of microRNA-490-3p restrained proliferation, migration, invasion and stimulated apoptosis of GC cells, which was attenuated by overexpression of AURKA.
CONCLUSIONS: MicroRNA-490-3p was likely to restrain the development of GC cells by inhibiting AURKA, and it may be an underlying target for GC treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34951005     DOI: 10.14670/HH-18-415

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  32 in total

1.  MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.

Authors:  Shuo Chen; Xi Chen; Yin-Ling Xiu; Kai-Xuan Sun; Yang Zhao
Journal:  Cancer Lett       Date:  2015-03-25       Impact factor: 8.679

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells.

Authors:  Patrizia Cammareri; Alessandro Scopelliti; Matilde Todaro; Vincenzo Eterno; Federica Francescangeli; Mary Pat Moyer; Antonino Agrusa; Francesco Dieli; Ann Zeuner; Giorgio Stassi
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

Review 4.  Gastric cancer.

Authors:  Vincenzo Catalano; Roberto Labianca; Giordano D Beretta; Gemma Gatta; Filippo de Braud; Eric Van Cutsem
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-20       Impact factor: 6.312

Review 5.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

6.  Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.

Authors:  T-V Do; F Xiao; L E Bickel; A J Klein-Szanto; H B Pathak; X Hua; C Howe; S W O'Brien; M Maglaty; J A Ecsedy; S Litwin; E A Golemis; R J Schilder; A K Godwin; D C Connolly
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

Review 7.  Advanced gastric cancer: Current treatment landscape and future perspectives.

Authors:  Antonia Digklia; Anna Dorothea Wagner
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

8.  miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.

Authors:  Zheng Fang; Shuai Yin; Ruochuan Sun; Shangxin Zhang; Min Fu; Youliang Wu; Tao Zhang; Junaid Khaliq; Yongxiang Li
Journal:  Mol Cancer       Date:  2017-08-17       Impact factor: 27.401

9.  Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers.

Authors:  Ahmed Gomaa; Dunfa Peng; Zheng Chen; Mohammed Soutto; Khaled Abouelezz; Alejandro Corvalan; Wael El-Rifai
Journal:  Sci Rep       Date:  2019-11-18       Impact factor: 4.379

Review 10.  Aurora Kinase Inhibitors: Current Status and Outlook.

Authors:  Vassilios Bavetsias; Spiros Linardopoulos
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.